Treatment with weak electromagnetic fields attenuates carbohydrate craving in a patient with multiple sclerosis

International Journal of Neuroscience

Volumn 86, Issue 1-2, 1996, Pages 67-77

  Sandyk, Reuven ^a,b,c  

^a NeuroCommunication Res Laboratories   (United States)

^b TOURO COLLEGE   (United States)

^c NONE   (United States)

Author keywords

carbohydrate craving; electromagnetic fields; medial hypothalamus; melatonin; Multiple sclerosis; pineal gland; seasonal affective disorder; serotonin (5 HT)

Indexed keywords

EID: 0030186146     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459608986699     Document Type: Article

References (111)

1. Acheson, E. D. (1977). Epidemiology of multiple sclerosis. British Medical Bulletin, 33, 9-14.
2. Arendt, J. (1989). Melatonin: a new probe in psychiatric investigations? British Journal of Psychiatry, 155, 585-590.
3. Bamford, C. R., Sibley, W. A. & Thies, C. (1983). Seasonal variation of MS exacerbations in Arizona Neurology, 33, 1537-1544.
4. Bell, I. R. (1976). Diet histories in narcolepsy. In C. Guilleminault, W. C Dement & P. Passouant (Eds.), Narcolepsy (pp. 221-227). New York: Spectrum.
5. Blehar, M. C. & Rosenthal, N. E. (1989). Seasonal affective disorders and phototherapy Archives of General Psychiatry, 46, 469-474.
6. Blundell, J. E. (1984). Serotonin and appetite. Neuropharmacology, 23, 1537-1551.
7. Brooks, D. N. (1972). Memory and head injury. Journal of Nervous and Mental Disease, 155, 350-355.
8. Carlsson, A., Svennerholm, L. & Winblad, B. (1980). Seasonal and circadian monoamine variations in human brains examined post-mortem. Acta Psychiatrica Scandinavica, 61 (suppl 280), 75-85.
9. Clark, C. M., Fleming, J. A., Li, D., Oger, J., Klonoff, H. & Paty, D. (1992) Sleep disturbance, depression, and lesion site in multiple sclerosis. Archives of Neurology, 49, 641-643.
10. Claveria, L. E., Curzon, G., Harrison, M. J. G. & Kantamaneni, B. D. (1974). Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 37, 715-718.
11. Clifford, D. B. & Trotter, J. L. (1984). Pain in multiple sclerosis. Archives of Neurology, 41, 1270-1272.
12. Cremer-Bartels, G., Krause, K. & Kuechle, H. J. (1983). Influence of low magnetic field-strength variations on the retina and pineal gland of quails and humans. Graefe's Archives of Clinical and Experimental Ophthalmology, 220, 248-252.
13. Dalton, K. (1964) The premenstrual syndrome. Springfield, IL: Charles C. Thomas.
14. Davidson, D., Pullar, I. A., Mawdsley, C., Kinloch, N. & Yates, C. M. (1977). Monoamine metabolites in cerebrospinal fluid in multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry, 40, 741-745.
15. De Castro, J. M. (1991). Seasonal rhythms of human nutrient intake and meal pattern. Physiology & Behavior, 50, 243-248.
16. Demaine, C. & Semm, P (1985). The avian pineal gland as an independent magnetic sensor. Neuroscience Letters, 62, 119-122
17. Desor, J. A., Maller, O. & Turner, R. E. (1973). Taste in acceptance of sugar by human infants. Journal of Comparative Physiology and Psychology, 84, 496-501.
18. Fernstrom, J. D. & Wurtman, R. J. (1972). Brain serotonin content: physiological regulation by plasma neutral amino acids. Science, 178, 414-416.
19. Fernstrom, J. D., Larin, F. & Wurtman, R. J. (1973). Correlations between brain tryptophan and plasma neutral amino acids levels following food consumption in rats. Life Sciences, 13, 517-524.
20. Fischman, H. R. (1981). Multiple sclerosis. a two stage process? American Journal of Epidemiology, 114, 244-252.
21. Flax, J. W., Gray, J. & Herbert, J. (1991). Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry, 148, 1603.
22. Fletcher, P. J. & Burton, M. J. (1984). Effects of manipulations of peripheral serotonin on feeding and drinking in the rat. Pharmacology Biochemistry and Behavior, 20, 835-840.
23. Garvey, M. J., Wesner, R. & Godes, M. (1988). Comparison of seasonal and nonseasonal affective disorder. American Journal of Psychiatry, 145, 100-102.
24. Hopf, H. C., Johnson, E. A. & Gutmann, L. (1992). Protective effect of serotonin on migraine attacks. Neurology, 42, 1419.
25. Hunt, N. & Silverstone, T. (1990). Seasonal affective disorder following brain injury. British Journal of Psychiatry, 156, 884-886.
26. Hyyppa, M. T , Jolma, T., Riekkinen, P. & Rinne, U. K. (1975). Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission, 37, 297-304.
27. Jankovic, B. D., Isakovic, K. & Petrovic, S. (1970). Effect of pinealectomy on immune reactions in the rat. Immunology, 18, 1-5.
28. Johansson, B. & Ross, B. E (1977). 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology, 11, 37-45.
29. Kay, R. W. (1994). Geomagnetic storms: association with incidence of depression as measured by hospital admission. British Journal of Psychiatry, 164, 403-409.
30. Kellner, C. H., Davenport, Y., Post, R M. & Ross, R. J. (1984). Rapidly cycling bipolar disorder and multiple sclerosis. American Journal of Psychiatry, 141, 112-113.
31. Klein, D. C., Smoot, R., Weller, J. L., Higa, S., Markey, S. P., Creed, G. J. & Jacobowitz, D. M. (1983). Lesions of the paraventricular nucleus area of the hypothalamus disrupt the suprachiasmatic-spinal cord circuit in the melatonin rhythm generating system. Brain Research Bulletin, 10, 647-652.
32. Johnson, R. T. (1994). The virology of demyelinating diseases. Annals of Neurology, 36, S54-S60.
33. Kolb, B. & Whishaw, I. Q. (1990). Fundamentals of human neuropsychology (pp. 455-456). New York: W H. Freeman and Company.
34. Krauchi, K. & Wirz-Justice, A. (1988). The four seasons food intake in seasonal affective disorder in the course of a year. Psychiatry Research, 25, 323-338.
35. Krauchi, K., Wirz-Justice, A. & Graw, P. (1990). The relationship of affective state to dietary preference: winter depression and light therapy as a model. Journal of Affective Disorder, 20, 43-53.
36. Kurtzke, J. F. (1965). On the time of onset in multiple sclerosis. Acta Neurologica Scandinavica, 44, 140-158.
37. Kurtzke, J. F. & Hyllested, K. (1979). Multiple sclerosis in the Faroe Islands: I. clinical and epidemiological features. Annals of Neurology, 5, 6-21.
38. Kurtzke, J. F., Kurland, L. T. & Goldberg, I. D. (1973). Multiple sclerosis In L. T. Kurland, J F. Kurtzke, J. F. & I. D. Goldberg (Eds.), Epidemiology of neurologic and sense organ disorders. Cambridge, MA: Harvard University Press.
39. Lance, J. W. (1978). Migraine. In W. B. Matthews & G. H Glaser (Eds.), Recent advances in clinical neurology (pp. 145-161). Edinburgh: Churchill Livingstone.
40. Leibowitz, S. F. (1986) Brain monoamines and peptides: role in the control of eating behaviour. Federation Proceedings, 45, 1396-1403.
41. Leibowitz, S. F., Weiss, G. F. & Shor-Posner, G. (1988). Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action. Clinical Neuropharmacology, 11, (suppl, 1), S51-S71.
42. Lerchl, A., Nonaka, K. O., Stokkan, K. A & Reiter, R. J. (1990). Marked rapid alterations in nocturnal pineal serotonin metabolism in mice and rats exposed to weak intermittent magnetic fields. Biochemical and Biophysical Research Communications, 169, 102-108.
43. Levitt, A. J., Brown, G. M., Kennedy, S. H. & Stern, K (1991). Tryptophan treatment and melatonin response in a patient with seasonal affective disorder. Journal of Clinical Psychopharmacology, 11, 74-75.
44. Lewy, A. J., Sack, R. L. & Miller, S. (1987). Antidepressants and circadian phase shifting effects of light. Science, 235, 352-354.
45. Lezak, M. D (1983). Neuropsychological assessment (pp. 404-405). second Edition. New York: Oxford University Press.
46. Lyons & Truswell (1988). Serotonin precursor influenced by type of carbohydrate meal in healthy adults. American Journal of Clinical Nutrition, 47, 433-439.
47. MacKenzie, R. G. & Trulson, M. E. (1978). Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats. Journal of Neurochemistry, 30, 205-211.
48. Maestroni, G. J. M., Conti, A. & Pierpaoli, W. (1987). The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science, 496, 67-77.
49. Matthews, W. B. (1975). Paroxysmal symptoms in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 38, 617-623.
50. McGrath, R. E., Buckwald, B. & Resnick, E V. (1990). The effect of L-tryptophan on seasonal affective disorder. Journal of Clinical Psychiatry, 51, 161-163.
51. Monaco, F., Fumero, S , Mondino, A. & Mutani, R. (1979). Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry, 42, 640-641.
52. 1 receptors. Psychopharmacology, 97, 213-218.
53. Olcese, J., Reuss, S. & Vollrath, L. (1985). Evidence for the involvement of the visual system in mediating magnetic field effects on pineal melatonin synthesis in the rat. Brain Research, 333, 382-384.
54. Olcese, J., Reuss, S., Stehle, J., Steinlechner, S. & Vollrath, L. (1988). Responses of the mammalian retina to experimental alteration of the ambient magnetic field. Brain Research, 448, 325-330.
55. Oliveras, J. L. & Besson, J. M. (1992). Serolonin, stimulation-produced analgesia and spinal mechanisms of antinociception. In P. B. Bradley, S. L. Handley, S. J. Cooper, B. J. Key, N. M. Barnes, & J. H. Coote (Eds.), Advances in the biosciences: serotonin, CNS receptors and brain function, vol. 85 (pp. 383-406) Oxford: Pergamon Press.
56. O'Rourke, D., Wurtman, J., Brzezinski, A., Abou-Nader, T., Marchant, P. & Wurtman, R. J. (1987). Treatment of seasonal affective disorder with d-fenfluramine. Annals of the New York Academy of Sciences, 499, 329-330.
57. O'Rourke, D , Wurtman, J. J., Wurtman, R. J., Chebli, R. & Gleason, R. (1989). Treatment of seasonal depression with d-fenfluramine. Journal of Clinical Psychiatry, 50, 343-347.
58. Pierpaoli, W. & Maestroni, G. J. M. (1988) Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience, 39, 165-175.
59. Reiter, R. J. & Richardson, B A. (1992). Magnetic fields effects on pineal indoleamine metabolism and possible biological consequences. FASEB Journal, 6, 2283-2287.
60. Rella, W. & Lapin, V (1976). Immunocompetence of pinealectomized and simulateneously pinealectomized and thymectomized rats. Oncology, 33, 3-6.
61. Reuss, S. & Olcese, J. (1986) Magnetic field effects of the rat pineal gland: role of retinal activation by light Neuroscience Letters, 64, 97-101.
62. Rosen, L. N., Livingstone, I. R. & Rosenthal, N. E. (1991). Multiple sclerosis and latitude: a new perspective on an old association. Medical Hypotheses, 36, 376-378.
63. Rosenthal, N. E. & Heffernan, M. M (1986). Bulimia, carbohydrate craving, and depression: a central connection? In R. J. Wurtman & J. J. Wurtman (Eds.), Nutrition and the brain, vol. 7 (pp. 139-166) New York. Raven Press.
64. Rosenthal, N. E., Sack, D. A., James, S P , Parry, B. L., Mendelson, W. B., Tamarkin, L. & Wehr, T. A. (1984). Seasonal affective disorder and phototherapy Presented at the New York Academy of Sciences. November, 1984.
65. Rosenthal, N E., Sack, D. A., Carpenter, C. J., Parry, B. L., Mendelson, W. B. & Wehr, T A. (1985). Antidepressant effects of light in seasonal affective disorder. American Journal of Psychiatry, 142, 163-170.
66. Rosenthal, N. E., Jacobsen, F. M., Sack, D. A., Arendt, J., James, S P., Parry, B. L. & Wehr, T. A. (1988) Atenolol in seasonal affective disorder: a test of the melatonin hypothesis. American Journal of Psychiatry, 145, 52-56.
67. Roszman, T. L., Jackson, J. C., Cross, R. J., Titus, M. J., Markesbery, W. R. & Brooks, W. H. (1985). Neuroanatomic and neurotransmitter influences on immune function. Journal of Immunology, 135, 769S-772S.
68. Sandyk, R. (1992 a). Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience, 66, 237-250.
69. Sandyk, R. (1992 b). The pineal gland and multiple sclerosis. (Editorial). International Journal of Neuroscience, 63, 206-215.
70. Sandyk, R. (1993) Multiple sclerosis: The role of puberty and the pineal gland in its pathogenesis. International Journal of Neuroscience, 68, 209-225.
71. Sandyk, R. (1994). Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience, 77, 243-259.
72. Sandyk, R. (1995). Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields International Journal of Neuroscience, 82, 223-242.
73. Sandyk, R. & Awerbuch, G. I. (1992). Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience, 67, 173-186.
74. Sandyk, R. & Awerbuch, G I (1993 a). Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience, 68, 227-240.
75. Sandyk, R. & Awerbuch, G. I. (1993 b). Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. International Journal of Neuroscience, 71, 147-157
76. Sandyk, R. & Derpapas, K. (1993 a). Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience, 68, 241-253.
77. Sandyk, R. & Derpapas, K. (1993 b). Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience, 70, 97-105.
78. Sandyk, R. & Iacono, R. P. (1993). Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience, 70, 255-269.
79. Sandyk, R & Awerbuch, G. I. (1994). The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link. International Journal of Neuroscience, 76, 249-257.
80. Sandyk, R. & Dann, L. C. (1994). Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience, 79, 199-212.
81. Sandyk, R. & Iacono, R. P. (1994). Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience, 78, 53-66.
82. Sandyk, R. Dann, L. C. (1995). Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience, 81, 215-224.
83. Sandyk, R., Anninos, P A. & Tsagas, N. (1991). Magnetic fields and seasonality of affective illness: implications for therapy. International Journal of Neuroscience, 58, 261-267.
84. Schiffer, R. B. & Babigian, H. M. (1984). Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: an epidemiologic study. Archives of Neurology, 41, 1067-1069.
85. Schiffer, R. B., Wineman, N. M. & Weitkamp, L. R. (1986) Association between bipolart affective disorder and multiple sclerosis. American Journal of Psychiatry; 143, 94-95.
86. Semm, P. (1983). Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology, 76A, 683-689.
87. Semm, P., Schneider, T. & Vollrath, L (1980). Effects of an earth-strengh magnetic field on electrical activity of pineal cells. Nature, 288, 607-608.
88. Sharma, H. S & Dey, P. K. (1986). Probable involvement of 5-hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats Neuropharmacology, 25, 161-167
89. Skwerer, R G., Jacobson, F. M., Duncan, C. C., Kelly, K. A., Sack, D. A., Tamarkin, L , Gaist, P. A., Kasper, S. & Rosenthal, N. E. (1988). Neurobiology of seasonal affective disorder and phototherapy. Journal of Biological Rhythms, 3, 135-154.
90. Smale, L., Cassone, V. M., Moore, R. Y. & Morin, L. P (1989). Paraventricular nucleus projections mediating pineal melatonin and gonadal responses to photoperiod in the hamster. Brain Research Bulletin, 22, 263-269.
91. Sonninen, V., Riekkinen, P. & Rinne, U. K. (1973). Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology, 23, 760-763.
92. Tabaddor, K., Wolfson, L. I. & Sharpless, N. S. (1978). Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurology, 28, 1249-1253.
93. Taylor, L. B. (1969). Localization of cerebral lesions by psychological testing. Clinical Neurosurgery, 16, 269-287.
94. Terman, M., Terman, J. S. & Quitkin, F. M. (1989). Light therapy for seasonal affective disorder. Neuropsychopharmacology, 2, 1-22.
95. Thompson, C. & Isaacs, G. (1988). Seasonal affective disorder- a British sample. Journal of Affective Disorders. 14, 1-11.
96. Wainerdi, H. R. (1961). Does the multiple-sclerosis syndrome begin at puberty? Boston Medical Quarterly, 12, 44-47.
97. Warren, S. & Warren, K G. (1981). Multiple sclerosis and associated diseases: A relationship to diabetes mellitus. Canadian Journal of Neurological Sciences, 8, 35-39.
98. Warren, S. A. & Warren, K G. (1982). Multiple sclerosis and diabetes mellitus: Further evidence for a relationship. Canadian Journal of Neurological Sciences, 11, 415-419.
99. Watkins, S. & Espir, M. (1969). Migraine and multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 32, 35-37.
100. Wehr, T. A. & Rosenthal, N. E. (1989). Seasonality and affective illness. American Journal of Psychiatry, 146, 829-839.
101. Wurtman, R. J. (1980). Nutritional control of brain tryptophan and serotonin. In O Hayashi, Y. Ishimura & R. Kido (Eds.), Biochenical and medical aspects of tryptophan metabolism (pp. 31-46). Amsterdam: Elsevier/North Holland.
102. Wurtman, R. J. (1982). Nutrients that modify brain function. Scientific American, 246, 42-51.
103. Wurtman, R. J. & Fernstrom, J. D. (1976). Control of brain neurotransmitter synthesis by precursor availability and nutritional state. Biochemical Pharmacology, 25, 1691-1696.
104. Wurtman, R. J. & Wurtman, J. J. (1984 a). Nutritional control of central neurotransmitters. In K. M. Pirke & D. Ploog (Eds.), The psychobiology of anorexia nervosa (pp. 4-11). Berlin: Springer Verlag.
105. Wurtman, R J & Wurtman, J. J. (1984 b). Impaired control of appetite for carbohydrates in some patients with eating disorders: treatment with pharmacologic agents. In K. M. Pirke & D. Ploog (Eds.), The psychobiology of anorexia nervosa (pp 12-21). Berlin: Springer Verlag.
106. Wurtman, R. J. & Wurtman, J. J. (1989). Carbohydrates and depression. Scientific American, January, 68-75.
107. Wurtman, R. J , Hefti, F. & Melamed, E. (1981). Precursor control of neurotransmitter synthesis. Pharmacological Reviews. 32, 315-335.
108. Wurtman, J. J., Wurtman, R. J., Growdon, J. H., Henry, P., Lipscomb, A. & Zeisel, S. H. (1981). Carbohydrate craving in obese people, suppression by treatments affecting serotonergic transmission. International Journal of Eating Disorders, 1, 2-15.
109. Wurtman, J. J., Wurtman, R. J , Mark, S., Tsay, R , Gilbert, W. & Growdon, J. (1985). D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects. International Journal of Eating Disorders, 4, 89-99.
110. Young, S. N. (1986). The clinical psychopharmacology of tryptophan. In Wurtman, R. J. & Wurtman, J. J. (Eds.), Nutrition and the brain (pp. 49-88). vol. 7. New York. Raven Press.
111. Zimmermann, R. C., McDougle, C. J., Schumacher, M., Olcese, J., Mason, J. W., Heninger, G. R. & Price, L. H. (1993). Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. Journal of Clinical Endocrinology and Metabolism, 76, 1160-1164.